CytomX Therapeutics (CTMX) Amortizatization of Intangibles (2014 - 2026)
CytomX Therapeutics' (CTMX) quarterly Amortizatization of Intangibles came in at $726000.0 in Q1 2026, up 59.91% YoY from $454000.0 in Q1 2025, and up 0.97% on a QoQ basis from $719000.0 in Q4 2025.
CytomX Therapeutics (CTMX) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
CytomX Therapeutics (CTMX) has 13 years of Amortizatization of Intangibles data on file, last reported at $726000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 59.91% year-over-year to $726000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 36.45% YoY) and the FY2025 annual result came in at $2.2 million, down 58.46% from the prior year.
- Amortizatization of Intangibles grew to $726000.0 in Q1 2026, from $719000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.2 million in Q4 2023 to a low of $5000.0 in Q4 2022.
- A 5-year average of $924352.9 and a median of $726000.0 in 2026 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 44420.0% — and 2025, when it sank 75.67%.
- Tracing CTMX's Amortizatization of Intangibles over 5 years: stood at $5000.0 in 2022, then jumped by 44420.0% to $2.2 million in 2023, then slumped by 64.65% to $787000.0 in 2024, then slipped by 8.64% to $719000.0 in 2025, then grew by 0.97% to $726000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $726000.0 (Q1 2026), $719000.0 (Q4 2025), and $636000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.43 Mn |
| Jun 30, 2026 | 1.43 Mn |
| Mar 31, 2026 | 726,000.00 |
| Mar 31, 2026 | 726,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Sep 30, 2025 | 636,000.00 |
| Sep 30, 2025 | 636,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | 454,000.00 |
| Mar 31, 2025 | 454,000.00 |
| Dec 31, 2024 | 787,000.00 |
| Dec 31, 2024 | 787,000.00 |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.87 Mn |